VistaGen Therapeutics, Inc. (VSTA) – Developing Leading-Edge Biotechnology Offerings
VistaGen Therapeutics is bringing human biology to the front end of the long and costly drug development process. Among the most troubling aspects of drug development are unexpected heart and liver toxicities that often arise during human testing. Applying its stem cell technology and the human heart and liver cells it produces from stem cells, the company’s new generation of customized biological assay systems have been designed to predict early in development how humans will respond to new drug candidates in the long run. In the years since VistaGen was founded, its technological advancements are finally catching on and allowing…